GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
5UJZ | 5UJZ | CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 1 | Hemagglutinin HA1, Hemagglutinin HA2, scFv |
5UK0 | 5UK0 | CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 2 | Hemagglutinin HA1, Hemagglutinin HA2, scFV |
5UK1 | 5UK1 | CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 3 | Hemagglutinin HA1, Hemagglutinin HA2, scFv |
5UK2 | 5UK2 | CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 4 | Hemagglutinin HA1, Hemagglutinin HA2, scFv |
5UKR | 5UKR | Structure of unliganded anti-gp120 CD4bs antibody DH522.2 Fab in complex with a gp120 core | |
5UM8 | 5UM8 | Crystal structure of HIV-1 envelope trimer 16055 NFL TD CC (T569G) in complex with Fabs 35022 and PGT124 | |
5UMN | 5UMN | Crystal structure of C05 VPGSGW mutant bound to H3 influenza hemagglutinin, HA1 subunit | |
5UN8 | 5UN8 | Crystal Structure of human O-GlcNAcase in complex with glycopeptide p53 | |
5UOW | 5UOW | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, MK-801 and a GluN2B-specific Fab, at pH 6.5 | N-methyl-D-aspartate receptor subunit NR1-8a, N-methyl-D-aspartate receptor subunit NR2A, Ionotropic glutamate receptor subunit NR2B, chain F |
5UP2 | 5UP2 | Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, Ro 25-6981, MK-801 and a GluN2B-specific Fab, at pH 6.5 | N-methyl-D-aspartate receptor subunit NR1-8a, N-methyl-D-aspartate receptor subunit NR2A, Ionotropic glutamate receptor subunit NR2B, chainF |
5UQY | 5UQY | Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78 | |
5UTF | 5UTF | Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M in Complex with Human Antibodies PGT122 and 35O22 at 4.3 A | |
5UTY | 5UTY | Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, N300M, N302M, T320L in Complex with Human Antibodies PGT122 and 35O22 at 4.1 Angstrom | |
5UUY | 5UUY | Crystal structure of Dioclea lasiocarpa lectin (DLL) complexed with X-MAN | |
5V2A | 5V2A | Crystal structure of Fab H7.167 in complex with influenza virus hemagglutinin from A/Shanghai/02/2013 (H7N9) | |
5V4M | 5V4M | Structure of HLA-DR15 with bound alpha3(135-145) peptide | HLA-DRA1, alpha3(135-145)-HLA-DRB1*15:01 |
5V4M | 5V4M | Structure of HLA-DR15 with bound alpha3(135-145) peptide | HLA-DRA1, alpha3(135-145)-HLA-DRB1*15:01 |
5V4N | 5V4N | Structure of HLA-DR1 with bound alpha3(135-145) peptide | |
5V4N | 5V4N | Structure of HLA-DR1 with bound alpha3(135-145) peptide | |
5V7J | 5V7J | Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22. | |
5V8L | 5V8L | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 | gp120, gp41, 3BNC117 antibody, heavy chain, PGT145 antibody, heavy chain, 3BNC117 antibody, light chain, PGT145 antibody, light chain |
5V8M | 5V8M | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 | gp120, gp41, antibody 3BNC117, heavy chain, antibody 3BNC117, light chain |
5VAK | 5VAK | Crystal Structure of Beta-Klotho, Domain 1 | Beta-klotho, Nb914 |
5VAN | 5VAN | Crystal Structure of Beta-Klotho | Beta-klotho, Nb914 |
5VAQ | 5VAQ | Crystal Structure of Beta-Klotho in Complex with FGF21CT | Beta-klotho, Nb914, Fibroblast growth factor 21 |
5VCJ | 5VCJ | Structure of alpha-galactosylphytosphingosine bound by CD1d and in complex with the Va14Vb8.2 TCR | |
5VCN | 5VCN | THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8 | |
5VCO | 5VCO | THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9 | |
5VEB | 5VEB | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
5VEB | 5VEB | Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 | |
5VF2 | 5VF2 | scFv 2D10 re-refined as a complex with trehalose replacing the original alpha-1,6-mannobiose | |
5VGJ | 5VGJ | Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90, bound to a scaffolded WITO V1V2 domain | |
5VH5 | 5VH5 | Crystal Structure of Fc fragment of anti-TNFa antibody infliximab | |
5VIE | 5VIE | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase | |
5VIF | 5VIF | Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase | |
5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain |
5VK2 | 5VK2 | Structural basis for antibody-mediated neutralization of Lassa virus | |
5VL3 | 5VL3 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
5VL3 | 5VL3 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
5VLI | 5VLI | Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934) | |
5VN3 | 5VN3 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
5VN8 | 5VN8 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | 5VOC | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | 5VOC | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOD | 5VOD | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
5VOD | 5VOD | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
5VPG | 5VPG | CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024